Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 25/03/20251 min di lettura
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →